A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis

Treatments in Respiratory Medicine

Volumn 4, Issue 4, 2005, Pages 289-296

  Meltzer, Eli O ^a   Bardelas, Jose ^b   Goldsobel, Alan ^c   Kaiser, Harold ^d  

^a ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^b Allergy and Asthma Center of NCPA   (United States)

^c Allergy & Asthma Associates of Northern California   (United States)

^d Allergy and Asthma Specialists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE; MOMETASONE FUROATE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ODOR; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SENSORY EVALUATION; TASTE; TIME SERIES ANALYSIS;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AGED; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; DOUBLE-BLIND METHOD; HUMANS; MIDDLE AGED; PATIENT SATISFACTION; PREGNADIENEDIOLS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 24344451143     PISSN: 11763450     EISSN: 11763450     Source Type: Journal    
DOI: 10.2165/00151829-200504040-00007     Document Type: Article

References (20)

1. D'Alonzo Jr GE. Scope and impact of allergic rhinitis. J Am Osteopath Assoc 2002; 102: S2-6
2. Bousquet J, Van Cauwenberge P, Bachert C, et al. Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy 2003; 58: 192-7
3. Tripathi A, Patterson R. Impact of allergic rhinitis treatment on quality of life. Pharmacoeconomics 2001; 19 (9): 891-9
4. Roper Public Affairs Group of NOP World. Impact of nasal congestion among allergic rhinitis sufferers. May-Jun 2004
5. Ferguson BJ. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg 2004; 130: 617-29
6. Skoner DP. Complications of allergic rhinitis. J Allergy Clin Immunol 2000; 105: S605-9
7. American Academy of Allergy, Asthma & Immunology, Inc. Allergic disorders: promoting best practice [online]. Available from URL: http://www.theallergyreport.org/reportindex.html [Accessed 2005; June]
8. Linneberg A, Henrik Nielsen N, Frolund L, et al. The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study. Allergy 2002; 57: 1048-52
9. Bachert C, El-Akkad T. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis. Ann Allergy Asthma Immunol 2002; 89: 292-7
10. Shah SR, Miller C, Pethick N, et al. Two multicenter, randomized, single-blind, single-dose, crossover studies of specific sensory attributes of budesonide aqueous nasal spray and fluticasone propionate nasal spray. Clin Ther 2003; 25: 2198-214
11. Meltzer EO, Hadley J, Blaiss M, et al. Development of questionnaires to measure patient preferences for intranasal corticosteroids in patients with allergic rhinitis. Otolaryngol Head Neck Surg 2005; 132: 197-207
12. Brannan MD, Herron JM, Affrime MB. Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children. Clin Ther 1997; 19: 1330-9
13. Hebert JR, Nolop K, Lutsky BN. Once-daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: an active- and placebo-controlled study. Allergy 1996; 51: 569-76
14. Mandl M, Nolop K, Lutsky BN. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis: 194-079 study group. Ann Allergy Asthma Immunol 1997; 79: 370-8
15. Graft D, Aaronson D, Chervinsky P, et al. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray. J Allergy Clin Immunol 1996; 98: 724-31
16. The European Agency for the Evaluation of Medicinal Products. ICH topic E6. Guideline for good clinical practice. 2002
17. Gart JJ. An exact test for comparing matched proportions in crossover designs. Biometrika 1969; 56: 75-80
18. Lachin JM. Biostatistical methods. John Wiley & Sons, New York; 2000
19. Trangsrud AJ, Whitaker AL, Small RE. Intranasal corticosteroids for allergic rhinitis. Pharmacotherapy 2002; 22: 1458-67
20. Gerson I, Green L, Fishken D. Patient preference and sensory comparisons of nasal spray allergy medications. J Sens Stud 1999; 14: 491-6